Teleflex SG&A Expenses 2010-2025 | TFX
Teleflex annual/quarterly sg&a expenses history and growth rate from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Teleflex sg&a expenses for the quarter ending March 31, 2025 were $0.223B, a 8.29% decline year-over-year.
- Teleflex sg&a expenses for the twelve months ending March 31, 2025 were $0.975B, a 3.74% increase year-over-year.
- Teleflex annual sg&a expenses for 2024 were $0.995B, a 7.03% increase from 2023.
- Teleflex annual sg&a expenses for 2023 were $0.93B, a 7.65% increase from 2022.
- Teleflex annual sg&a expenses for 2022 were $0.864B, a 0.43% increase from 2021.
| Teleflex Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $995 |
| 2023 | $930 |
| 2022 | $864 |
| 2021 | $860 |
| 2020 | $744 |
| 2019 | $852 |
| 2018 | $797 |
| 2017 | $700 |
| 2016 | $563 |
| 2015 | $569 |
| 2014 | $579 |
| 2013 | $502 |
| 2012 | $454 |
| 2011 | $424 |
| 2010 | $404 |
| 2009 | $388 |
| Teleflex Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $223 |
| 2024-12-31 | $255 |
| 2024-09-30 | $247 |
| 2024-06-30 | $251 |
| 2024-03-31 | $243 |
| 2023-12-31 | $261 |
| 2023-09-30 | $213 |
| 2023-06-30 | $223 |
| 2023-03-31 | $233 |
| 2022-12-31 | $233 |
| 2022-09-30 | $210 |
| 2022-06-30 | $217 |
| 2022-03-31 | $204 |
| 2021-12-31 | $228 |
| 2021-09-30 | $205 |
| 2021-06-30 | $224 |
| 2021-03-31 | $203 |
| 2020-12-31 | $233 |
| 2020-09-30 | $172 |
| 2020-06-30 | $191 |
| 2020-03-31 | $148 |
| 2019-12-31 | $220 |
| 2019-09-30 | $209 |
| 2019-06-30 | $216 |
| 2019-03-31 | $207 |
| 2018-12-31 | $137 |
| 2018-09-30 | $215 |
| 2018-06-30 | $230 |
| 2018-03-31 | $215 |
| 2017-12-31 | $213 |
| 2017-09-30 | $164 |
| 2017-06-30 | $159 |
| 2017-03-31 | $164 |
| 2016-12-31 | $144 |
| 2016-09-30 | $140 |
| 2016-06-30 | $143 |
| 2016-03-31 | $136 |
| 2015-12-31 | $148 |
| 2015-09-30 | $139 |
| 2015-06-30 | $142 |
| 2015-03-31 | $140 |
| 2014-12-31 | $153 |
| 2014-09-30 | $138 |
| 2014-06-30 | $147 |
| 2014-03-31 | $140 |
| 2013-12-31 | $144 |
| 2013-09-30 | $115 |
| 2013-06-30 | $116 |
| 2013-03-31 | $127 |
| 2012-12-31 | $122 |
| 2012-09-30 | $115 |
| 2012-06-30 | $106 |
| 2012-03-31 | $112 |
| 2011-12-31 | $109 |
| 2011-09-30 | $102 |
| 2011-06-30 | $110 |
| 2011-03-31 | $103 |
| 2010-12-31 | $102 |
| 2010-09-30 | $102 |
| 2010-06-30 | $100 |
| 2010-03-31 | $101 |
| 2009-12-31 | $40 |
| 2009-09-30 | $114 |
| 2009-06-30 | $118 |
| 2009-03-31 | $117 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.586B | $3.047B |
| Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $189.754B | 83.11 |
| Thermo Fisher Scientific (TMO) | United States | $159.887B | 19.34 |
| Alcon (ALC) | Switzerland | $48.486B | 32.23 |
| Edwards Lifesciences (EW) | United States | $44.472B | 29.10 |
| IDEXX Laboratories (IDXX) | United States | $37.951B | 43.61 |
| DexCom (DXCM) | United States | $32.004B | 49.47 |
| IQVIA Holdings (IQV) | United States | $27.061B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.925B | 27.19 |
| STERIS (STE) | Ireland | $22.088B | 25.26 |
| Waters (WAT) | United States | $20.850B | 29.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.568B | 0.00 |
| Hologic (HOLX) | United States | $12.153B | 13.11 |
| Sysmex ADR (SSMXY) | Japan | $11.545B | 0.00 |
| Penumbra (PEN) | United States | $11.463B | 89.97 |
| Globus Medical (GMED) | United States | $9.891B | 22.90 |
| Masimo (MASI) | United States | $8.993B | 37.74 |
| Glaukos (GKOS) | United States | $5.006B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.385B | 22.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.077B | 0.00 |
| TransMedics (TMDX) | United States | $3.044B | 89.09 |
| Veracyte (VCYT) | United States | $2.377B | 42.75 |
| Nihon Kohden (NHNKY) | Japan | $2.113B | 11.55 |
| LivaNova (LIVN) | United Kingdom | $2.005B | 12.14 |
| Elekta AB (EKTAY) | Sweden | $1.960B | 17.62 |
| Alphatec Holdings (ATEC) | United States | $1.754B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.431B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.302B | 6.58 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.098B | 0.00 |
| Artivion (AORT) | United States | $0.996B | 93.32 |
| AxoGen (AXGN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 35.65 |
| Mesa Laboratories (MLAB) | United States | $0.647B | 14.14 |
| RxSight (RXST) | United States | $0.644B | 0.00 |
| SiBone (SIBN) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.565B | 9.10 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.513B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.457B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.36 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.333B | 17.82 |
| Neuronetics (STIM) | United States | $0.301B | 0.00 |
| CVRx (CVRX) | United States | $0.207B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.194B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.160B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.82 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |